Related references
Note: Only part of the references are listed.Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas A Clinicopathologic Analysis of 44 Cases
Olca Basturk et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Molecular Targeted Therapy in Enteropancreatic Neuroendocrine Tumors: From Biology to Clinical Practice
N. Fazio et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues
Marco Volante et al.
HUMAN PATHOLOGY (2014)
Tumor Staging But Not Grading Is Associated With Adverse Clinical Outcome in Neuroendocrine Tumors of the Appendix A Retrospective Clinical Pathologic Analysis of 138 Cases
Marco Volante et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
The Immunohistochemical Expression of Islet 1 and PAX8 by Rectal Neuroendocrine Tumors Should Be Taken into Account in the Differential Diagnosis of Metastatic Neuroendocrine Tumors of Unknown Primary Origin
Jamie Koo et al.
ENDOCRINE PATHOLOGY (2013)
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Fritz-Line Velayoudom-Cephise et al.
ENDOCRINE-RELATED CANCER (2013)
Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases
Stefano La Rosa et al.
HUMAN PATHOLOGY (2013)
ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin
Abbas Agaimy et al.
MODERN PATHOLOGY (2013)
The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine Carcinomas
James Smith et al.
SEMINARS IN ONCOLOGY (2013)
Colorectal Poorly Differentiated Neuroendocrine Carcinomas and Mixed Adenoneuroendocrine Carcinomas: Insights Into the Diagnostic Immunophenotype, Assessment of Methylation Profile, and Search for Prognostic Markers
Stefano La Rosa et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Shinichi Yachida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update
Stefano La Rosa et al.
Cancers (2012)
Gastroenteropancreatic (neuro)endocrine neoplasms: The histology report
Guido Rindi et al.
DIGESTIVE AND LIVER DISEASE (2011)
Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms
Stefano La Rosa et al.
HUMAN PATHOLOGY (2011)
High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease
Derek G. Power et al.
MEDICAL ONCOLOGY (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2
Gratiana Hermann et al.
VIRCHOWS ARCHIV (2011)
Immune infiltration in human tumors: a prognostic factor that should not be ignored
F. Pages et al.
ONCOGENE (2010)
TTF1 expression in normal lung neuroendocrine cells and related tumors: immunohistochemical study comparing two different monoclonal antibodies
Stefano La Rosa et al.
VIRCHOWS ARCHIV (2010)
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Jinru Shia et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases
Anja M. Schmitt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
Gastric large cell neuroendocrine carcinomas: A distinct clinicopathologic entity
Shi-Xu Jiang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma
Tsutomu Ishikubo et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R
DJ Gross et al.
ENDOCRINE-RELATED CANCER (2006)
Allelotypes and fluorescence in situ hybridization profiles of poorly differentiated endocrine carcinomas of different sites
D Furlan et al.
CLINICAL CANCER RESEARCH (2005)
CDX-2 homeobox gene product expression in neuroendocrine tumors - Its role as a marker of intestinal neuroendocrine tumors
M Barbareschi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors
S La Rosa et al.
VIRCHOWS ARCHIV (2004)
Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas
O Akintola-Ogunremi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Share Paper
